| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/29/2005 | CA2559662A1 Novel antibiotic alternatives |
| 09/29/2005 | CA2559552A1 Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors |
| 09/29/2005 | CA2559272A1 Novel peanut skin extract as a vaccine adjuvant |
| 09/29/2005 | CA2559229A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
| 09/29/2005 | CA2558629A1 Trihemihydrate, anhydrate and hydrate forms of cefdinir |
| 09/29/2005 | CA2557929A1 Benzodiazepines for treating or preventing or preventing rsv infection |
| 09/29/2005 | CA2557443A1 Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide |
| 09/29/2005 | CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 09/28/2005 | EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV) |
| 09/28/2005 | EP1579868A2 Use of IL-11 for treating various diseases |
| 09/28/2005 | EP1579864A1 Oxolide antibacterials |
| 09/28/2005 | EP1579001A2 Materials and methods for prevention and treatment of rna viral diseases |
| 09/28/2005 | EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/28/2005 | EP1578922A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 09/28/2005 | EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer |
| 09/28/2005 | EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578898A2 Nad synthetase inhibitors and uses thereof |
| 09/28/2005 | EP1578773A2 Methods and products based on oligomerization of stress proteins |
| 09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
| 09/28/2005 | EP1578750A2 Cationic porphyrin derivatives as antibacterial agents |
| 09/28/2005 | EP1578748A1 Tetrahydro-4h-pyrido [1, 2-a] pyrimidines and related compounds useful as hiv integrase inhibitors |
| 09/28/2005 | EP1578743A2 Antibacterial agents |
| 09/28/2005 | EP1578734A1 Novel antibacterial agents |
| 09/28/2005 | EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof |
| 09/28/2005 | EP1578429A2 Protease inhibitors |
| 09/28/2005 | EP1578353A2 Methods of use and compositions for the diagnosis and treatment of infectious disease |
| 09/28/2005 | EP1463731B1 Dibenzodiazepine derivates, their preparation and use |
| 09/28/2005 | EP1450838A4 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 09/28/2005 | EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 09/28/2005 | EP1420804A4 Methods and compositions for control of coccidiosis |
| 09/28/2005 | EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 09/28/2005 | EP1320357A4 Topical polymeric antimicrobial emulsion |
| 09/28/2005 | EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1178781B1 Multilayer pharmaceutical product for release in the colon |
| 09/28/2005 | EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/28/2005 | EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/28/2005 | EP1085804A4 Method and composition for the treatment of epidermal irritations and infections |
| 09/28/2005 | EP1008344B1 New dicaffeoylquinic acid derivatives and their use for treating hepatitis b |
| 09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 09/28/2005 | EP0912743B1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 09/28/2005 | CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
| 09/28/2005 | CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 09/28/2005 | CN1675229A Sulfur-containing phospholipid derivatives |
| 09/28/2005 | CN1675213A 新的嘌呤衍生物 New purine derivatives |
| 09/28/2005 | CN1675211A 新的嘌呤衍生物 New purine derivatives |
| 09/28/2005 | CN1675208A Novel fused imidazole derivative |
| 09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675192A Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674936A Treatment of MS with goat serum |
| 09/28/2005 | CN1674935A Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 09/28/2005 | CN1674932A Novel bacterium for treatment of disease |
| 09/28/2005 | CN1674925A Anti-microbial agent and anti-microbial composition |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674902A Novel crystalline forms of gatifloxacin |
| 09/28/2005 | CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| 09/28/2005 | CN1674894A Ether substituted imidazopyridines |
| 09/28/2005 | CN1674875A Anti-microbial compositions and methods of using same |
| 09/28/2005 | CN1674870A Liposomes containing biologically active compounds |
| 09/28/2005 | CN1674864A Topical formulation for prevention and treatment of acne |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1673368A HCV regulated proteins |
| 09/28/2005 | CN1673231A Monoclonal antibody of SARS coronavirus N protein and its application |
| 09/28/2005 | CN1673230A Prepn of recombinant composite interferon-polyglycol conjugate and conjugate product |
| 09/28/2005 | CN1672733A HIV-1 treating recombinant chicken pox virus vaccine |
| 09/28/2005 | CN1672732A Stable recombinant solid alpha-interferon composition |
| 09/28/2005 | CN1672731A Interferon spray for lung administration and its prepn process |
| 09/28/2005 | CN1672727A Cold-treating beverage and its prepn process |
| 09/28/2005 | CN1672717A SARS preventing and treating Chinese medicine prepn |
| 09/28/2005 | CN1672716A Chinese medicine granule for preventing and treating respiratory tract infection |
| 09/28/2005 | CN1672715A Recipe and production process of prepn of preventing and treating common cold |
| 09/28/2005 | CN1672714A Gastrointestinal decoction |
| 09/28/2005 | CN1672686A Dispersive asiaticoside tablet and its prepn process |
| 09/28/2005 | CN1672682A Prepn containing fibrauretine microcapsule and its prepn process |
| 09/28/2005 | CN1672681A Moxixacin capsule and its prepn process |
| 09/28/2005 | CN1672680A Stable moxixacin tablet and its prepn process |
| 09/28/2005 | CN1672676A Clamped beriberi treating medicated cotton |
| 09/28/2005 | CN1220700C Staphylococcus aureus virulence stimulating factor inhibiting peptide and its application |
| 09/28/2005 | CN1220697C Pyloric spirobacterium inhibitor |
| 09/28/2005 | CN1220693C Process for preparation of 3-sulfonyloxy-3-cephem compounds |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease |
| 09/28/2005 | CN1220505C Freeze-dried garlic powder preparation and its preparation method |
| 09/28/2005 | CN1220503C Medicine for treating hepatitis B |
| 09/28/2005 | CN1220500C Skin Chinese medicine disinfectant liquid and use in preparing medicine for suppressing prospermia |
| 09/28/2005 | CN1220497C Antivirus antioxidizing active extract of proplis and its molecular clathrate compound preparation |
| 09/28/2005 | CN1220496C Bougie for treating virus hepatitis and preparing method thereof |
| 09/28/2005 | CN1220495C Traditional Chinese medicine for treating upper respiratory tract infection and its preparation method |
| 09/27/2005 | US6949681 Intermediate for preparing glycopeptide derivatives |
| 09/27/2005 | US6949649 used as immunomodulators, for inducing cytokine biosynthesis in animals, and in the treatment of diseases, including viral and neoplastic diseases |
| 09/27/2005 | US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 09/27/2005 | US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders |
| 09/27/2005 | US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| 09/27/2005 | US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity |
| 09/27/2005 | US6949543 Amide derivative |
| 09/27/2005 | US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one |